SCHEMBL8868754

SCHEMBL8868754

CC(C)OC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3ccccc3)cc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.48
P4HTM Q9NXG6 3/20 0.48
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 3/20 0.44
RXFP1 Q9HBX9 1/20 0.43
HIF1A Q16665 1/20 0.42
ESRRG P62508 1/20 0.42
LMNA P02545 3/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868842 0.97 P4HTM (0.48) PPARAP4HTMMEN1KMT2ASMN1; SMN2
SCHEMBL8869237 0.93 PPARA (0.50) PPARAP4HTMMEN1KMT2ASMN1; SMN2
SCHEMBL8869489 0.93 PPARA (0.50) PPARAP4HTMMEN1KMT2ASMN1; SMN2
SCHEMBL8869206 0.92 P4HTM (0.47) PPARAP4HTMSMN1; SMN2NPC1RAB9A
SCHEMBL8869129 0.92 MAPT (0.49) PPARAP4HTMMEN1KMT2ASMN1; SMN2
SCHEMBL8868676 0.92 MAPT (0.49) PPARAP4HTMMEN1KMT2ASMN1; SMN2
SCHEMBL8869223 0.92 P4HTM (0.55) PPARAP4HTMMEN1KMT2ARAB9A
SCHEMBL8868677 0.92 MAPT (0.48) PPARAP4HTMMEN1KMT2ASMN1; SMN2
SCHEMBL8867444 0.92 P4HTM (0.46) PPARAP4HTMSMN1; SMN2NPC1RAB9A
SCHEMBL8868236 0.91 P4HTM (0.51) PPARAP4HTMMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed